| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/25/2002 | EP1242117A1 Method for treatment of canine distemper |
| 09/25/2002 | EP1242113A2 Methods and compositions for inhibiting adhesion by microorganisms |
| 09/25/2002 | EP1242109A2 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 09/25/2002 | EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
| 09/25/2002 | EP1242102A2 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 09/25/2002 | EP1242099A1 A method of treating infectious diseases |
| 09/25/2002 | EP1242096A2 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium |
| 09/25/2002 | EP1242082A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 09/25/2002 | EP1242079A1 Methods of use of fluoroquinolone compounds againts bacteria |
| 09/25/2002 | EP1242075A2 Indole compounds |
| 09/25/2002 | EP1242073A2 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/25/2002 | EP1242064A1 Liver selective therapy |
| 09/25/2002 | EP1242059A2 Novel prodrugs for antimicrobial amidines |
| 09/25/2002 | EP1175432A4 Processes for the synthesis of oligomers using phosphoramidite compositions |
| 09/25/2002 | EP1021405B1 Azetidinone derivatives for the treatment of hcmv infections |
| 09/25/2002 | EP1001951B1 Thiazole derivatives, method for their production and use |
| 09/25/2002 | EP0948345B1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 09/25/2002 | EP0918540B1 Intradermal bovine polynucleotide vaccine |
| 09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 09/25/2002 | EP0751948B1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 09/25/2002 | EP0746312B1 Guanylhydrazones for treating inflammatory conditions |
| 09/25/2002 | EP0652966B1 Method of increasing expression of viral proteins |
| 09/25/2002 | EP0641795B1 Carbapenem derivative |
| 09/25/2002 | CN1371416A Human CTLA-4 antibodies and their uses |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371386A Spherical telithromycikn clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 09/25/2002 | CN1371385A Immunopotentiating compositions |
| 09/25/2002 | CN1371381A Improved amorphous form of cefpodoxime proxetil |
| 09/25/2002 | CN1371378A 28-epirapalogs |
| 09/25/2002 | CN1371367A Phenethyl-5-bromopyridyl thiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity |
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/25/2002 | CN1371288A Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 09/25/2002 | CN1371285A Methods and compounds for treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 09/25/2002 | CN1371283A Use of propionic bacteria for producing propionic acid and/or propionates in colon |
| 09/25/2002 | CN1371282A Medicaments that contain xenogenic oligo-or/and polyribonucleotides |
| 09/25/2002 | CN1370596A Mass dissipating and swelling eliminating health beverage |
| 09/25/2002 | CN1370594A Chinese mediicne for treating women's menalgia, pelvic infection and vaginitis |
| 09/25/2002 | CN1370581A Fast tuberculosis-eliminating decoction and its prepn |
| 09/25/2002 | CN1370580A Chinese medicine for treating chronic salpingitis |
| 09/25/2002 | CN1370578A Medicine liquid for relieving asthma, relieving cough and eliminating phlegm |
| 09/25/2002 | CN1370574A Antiphlogistic bolus made of honeysuckle, antelope horn and gentian |
| 09/25/2002 | CN1370558A Antiviral Chinese medicine mixture and its prepn |
| 09/25/2002 | CN1370549A Common cold treating Chinese medicine and its prepn |
| 09/25/2002 | CN1370538A Medicinal composite containing staphdine and dideoxyinosine |
| 09/25/2002 | CN1370529A Medicine for treating spinal cord lesion |
| 09/25/2002 | CN1370527A Toxoprotein, medicament for toxoprotein caused disease and the disease preventing and treating method |
| 09/24/2002 | US6455680 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455669 Glycoprotein for use in the treatment and prevention of bacterial infections |
| 09/24/2002 | US6455592 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
| 09/24/2002 | US6455582 Treating cancer |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455571 Inhibitors of neuraminidases |
| 09/24/2002 | US6455562 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455530 2R,4S,S,S- and 2S,4R,S,S-hydroxyitraconazole |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455522 Cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 09/24/2002 | US6455513 Chemical compounds |
| 09/24/2002 | US6455508 Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
| 09/24/2002 | US6455507 Benzimidazole derivatives |
| 09/24/2002 | US6455506 Lyxofuranosyl benzimidazoles as antiviral agents |
| 09/24/2002 | US6455505 Derivatives . . . use as medicaments |
| 09/24/2002 | US6455503 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 09/24/2002 | US6455492 Hepatitis E virus vaccine and method |
| 09/24/2002 | US6455323 Contacting virulence protein with chemical compound, then identifying compounds which bind or interacts with protein; for bactericides against staphylococcus aureus |
| 09/24/2002 | US6455298 Animal cells and processes for the replication of influenza viruses |
| 09/24/2002 | US6455286 Psoralens for pathogen inactivation |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455265 Preparing candidate immunogenic agents based on an envelope protein of a pathogenic strain, then selecting a modified polypeptide which induces an immune response against the immunodomnant region of the protein but not the host |
| 09/24/2002 | US6455245 For immunoassay detection |
| 09/24/2002 | US6455078 Grinding and mixing the plant of diffuse hedyotis, dried rhizome of bistort rhizome, giant knotweed rhizome, dried ripe fruit of chinese magnoliviavine fruit to form mixture, boiling in water, filtering and concentrating the extract |
| 09/24/2002 | US6455045 Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455038 Administering reovirus for ras-mediated proliferative disorder, tumors |
| 09/24/2002 | CA2106683C Inactivating enveloped viruses and sperm |
| 09/24/2002 | CA2105487C Antiviral nucleoside combination |
| 09/24/2002 | CA2103223C Crystalline carbapenem derivative |
| 09/20/2002 | WO2001070692A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 09/20/2002 | CA2403807A1 Heterocyclic acylsulfimides,processes for their preparation,compositionscomprising them and their use as pesticides |
| 09/19/2002 | WO2002073208A2 Anti-epileptogenic agents |
| 09/19/2002 | WO2002072827A1 Traf3-binding b cell-specific receptor |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072637A1 Natural antibodie active against hiv virus |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072623A1 Genes and proteins, and their use |
| 09/19/2002 | WO2002072622A2 Vaccine antigens against infection by chlamydia trachomatis |
| 09/19/2002 | WO2002072621A2 Cyclohexapeptide having antimicrobial activity |
| 09/19/2002 | WO2002072620A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | WO2002072617A1 Thiopeptide compounds |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002072581A2 Pyrazolopyriadine derivatives |
| 09/19/2002 | WO2002072579A1 Triazolopyridines as anti-inflammatory agents |